Literature DB >> 16503503

Longitudinal analysis of T-cell receptor variable beta chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation.

Congxiao Liu1, Min He, Barbara Rooney, Thomas B Kepler, Nelson J Chao.   

Abstract

T-cell receptor variable beta chain (TCRBV) repertoire spectratyping involves the estimation of CDR3 length distributions for monitoring T-cell receptor diversity and has proven useful for analyses of immune reconstitution and T-cell clonal expansions in graft-versus-host disease (GVHD) and graft-versus-leukemia after allogeneic stem cell transplantation. We performed a longitudinal spectratype analysis of 23 TCRBV families in 28 patients who underwent allogeneic T cell-depleted peripheral blood stem cell transplantation. Sixteen patients subsequently developed acute GVHD. We recently developed statistical methods that bring increased power and flexibility to spectratype analysis and allow us to analyze TCRBV repertoire development under appropriately complex statistical models. Applying these methods, we found that patients with acute GVHD demonstrated TCRBV repertoire development statistically distinct from that repertoire development in patients without GVHD. Specifically, GVHD patients showed spectratypes indicative of lower diversity and greater deviation from the spectratypes expected in healthy individuals at intermediate times. Most individual TCRBV subfamilies had spectratypes statistically distinguishable between GVHD and non-GVHD patients at 6 months after transplantation. These results suggest that the T-cell receptor repertoire perturbations associated with acute GVHD are widely spread throughout the TCRBV families.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16503503     DOI: 10.1016/j.bbmt.2005.09.019

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  13 in total

Review 1.  Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation.

Authors:  Jenny Zilberberg; Rena Feinman; Robert Korngold
Journal:  Biol Blood Marrow Transplant       Date:  2014-11-20       Impact factor: 5.742

2.  T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.

Authors:  Jeremy A Meier; Mahdee Haque; Mohamed Fawaz; Hamdi Abdeen; David Coffey; Andrea Towlerton; Ahmed Abdeen; Abdullah Toor; Edus Warren; Jason Reed; Christopher G Kanakry; Armand Keating; Leo Luznik; Amir A Toor
Journal:  Biol Blood Marrow Transplant       Date:  2019-01-21       Impact factor: 5.742

3.  Clonotypic analysis of T cell reconstitution after haematopoietic stem cell transplantation (HSCT) in patients with severe combined immunodeficiency.

Authors:  H Okamoto; C Arii; F Shibata; T Toma; T Wada; M Inoue; Y Tone; Y Kasahara; S Koizumi; Y Kamachi; Y Ishida; J Inagaki; M Kato; T Morio; A Yachie
Journal:  Clin Exp Immunol       Date:  2007-03-21       Impact factor: 4.330

Review 4.  Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.

Authors:  Rohtesh S Mehta; Katayoun Rezvani
Journal:  Virulence       Date:  2016-07-06       Impact factor: 5.882

5.  Peptide/MHC tetramer-based sorting of CD8⁺ T cells to a leukemia antigen yields clonotypes drawn nonspecifically from an underlying restricted repertoire.

Authors:  Sally A Hunsucker; Colleen S McGary; Benjamin G Vincent; Atim A Enyenihi; Jennifer P Waugh; Karen P McKinnon; Lisa M Bixby; Patricia A Ropp; James M Coghill; William A Wood; Don A Gabriel; Stefanie Sarantopoulos; Thomas C Shea; Jonathan S Serody; Gheath Alatrash; Tania Rodriguez-Cruz; Gregory Lizée; Adam S Buntzman; Jeffrey A Frelinger; Gary L Glish; Paul M Armistead
Journal:  Cancer Immunol Res       Date:  2015-01-09       Impact factor: 11.151

6.  Analysis of the Whole CDR3 T Cell Receptor Repertoire after Hematopoietic Stem Cell Transplantation in 2 Clinical Cohorts.

Authors:  Omid Shah; John S Tamaresis; Laura Jean Kenyon; Liwen Xu; Pingping Zheng; Puja Gupta; Krish Rangarajan; Stephanie Lee; Stephen Spellman; Sarah Nikiforow; James Zehnder; Everett H Meyer
Journal:  Biol Blood Marrow Transplant       Date:  2020-02-18       Impact factor: 5.742

7.  Human T cells depend on functional calcineurin, tumour necrosis factor-α and CD80/CD86 for expansion and activation in mice.

Authors:  H Søndergaard; P H Kvist; C Haase
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

8.  T Cell Clonal Dynamics Determined by High-Resolution TCR-β Sequencing in Recipients after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Mark Leick; Rachel M Gittelman; Erik Yusko; Catherine Sanders; Harlan Robins; Zachariah DeFilipp; Sarah Nikiforow; Jerome Ritz; Yi-Bin Chen
Journal:  Biol Blood Marrow Transplant       Date:  2020-05-15       Impact factor: 5.742

9.  Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients.

Authors:  P Y Yew; H Alachkar; R Yamaguchi; K Kiyotani; H Fang; K L Yap; H T Liu; A Wickrema; A Artz; K van Besien; S Imoto; S Miyano; M R Bishop; W Stock; Y Nakamura
Journal:  Bone Marrow Transplant       Date:  2015-06-08       Impact factor: 5.483

Review 10.  The past, present, and future of immune repertoire biology - the rise of next-generation repertoire analysis.

Authors:  Adrien Six; Maria Encarnita Mariotti-Ferrandiz; Wahiba Chaara; Susana Magadan; Hang-Phuong Pham; Marie-Paule Lefranc; Thierry Mora; Véronique Thomas-Vaslin; Aleksandra M Walczak; Pierre Boudinot
Journal:  Front Immunol       Date:  2013-11-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.